Pre-exposure chemoprophylaxis for HIV: It is time
AUTOR(ES)
Smith, Stephen M
FONTE
BioMed Central
RESUMO
The HIV-1 plague continues unabatedly across sub-Saharan Africa. In Botswana and Swaziland, nearly 40% of the entire adult population is already infected. No current program is capable of slowing the advancing tide. An effective vaccine and widespread treatment are years, if not, decades away. In this most urgent situation, I propose that pre-exposure chemoprophylaxis be studied as a means to reduce the spread of HIV-1 among at-risk individuals.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=478616Documentos Relacionados
- Pre-exposure prophylaxis with immune serum globulin for prevention of viral hepatitis in army recruits.
- Concomitant stress potentiates the preference for, and consumption of, ethanol induced by chronic pre-exposure to ethanol
- Two Time Windows of Anisomycin-Induced Amnesia for Inhibitory Avoidance Training in Rats: Protection from Amnesia by Pretraining but not Pre-exposure to the Task Apparatus
- Othering discourse and stigma amidst the identity formation process among gays, bisexuals and other men who have sex with men on HIV pre-exposure prophylaxis (PrEP)
- Serological hepatitis A virus infections and ratio of clinical to serological infections in a controlled trial of pre-exposure prophylaxis with immune serum globulin.
